EQS-Adhoc

    153 Aufrufe 153 0 Kommentare 0 Kommentare

    CompuGroup Medical SE & Co. KGaA confirms discussions for potential significant investment of CVC

    Für Sie zusammengefasst
    • CompuGroup Medical in talks with CVC for investment.
    • Potential tender offer at EUR 22.00 per share discussed.
    • Gotthardt family to maintain 50.1% stake post-deal.
    EQS-Adhoc - CompuGroup Medical SE & Co. KGaA confirms discussions for potential significant investment of CVC

    EQS-Ad-hoc: CompuGroup Medical SE & Co. KGaA / Key word(s): Tender Offer
    CompuGroup Medical SE & Co. KGaA confirms discussions for potential significant investment of CVC

    08-Dec-2024 / 23:01 CET/CEST
    Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group AG.
    The issuer is solely responsible for the content of this announcement.


    CompuGroup Medical SE & Co. KGaA (Company) confirms that the Company and the shareholder group around the founding family Gotthardt are in advanced discussions with the private equity firm CVC Capital Partners plc (CVC) regarding a potential conclusion of an investment agreement for the submission of a voluntary public tender offer to the shareholders of the Company. The discussions also include a later delisting of shares of the Company from the regulated market. Starting point is a potential offer price of EUR 22.00 per share that CVC has indicated to the Company in the event of a public tender offer, which is subject, in particular, to final board decisions and the signing of transaction documents.

    In the event of the potential transaction being implemented, the shareholder group around the Gotthardt family intends to remain invested in the Company to the same extent as before, with around 50,1% and, subject to the outcome of the ongoing discussions, to establish a strategic partnership with CVC.

    The Company will inform the public and the capital market about further relevant developments in accordance with the legal requirements.
     


    End of Inside Information

    08-Dec-2024 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
    Archive at www.eqs-news.com


    Language: English
    Company: CompuGroup Medical SE & Co. KGaA
    Maria Trost 21
    56070 Koblenz
    Germany
    Phone: +49 (0)160 3630362
    Fax: +49 (0)261 8000 3200
    E-mail: investor@cgm.com
    Internet: www.cgm.com
    ISIN: DE000A288904
    WKN: A28890
    Indices: SDAX, TecDAX
    Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange
    EQS News ID: 2046393

     
    End of Announcement EQS News Service

    2046393  08-Dec-2024 CET/CEST

    fncls.ssp?fn=show_t_gif&application_id=2046393&application_name=news&site_id=wallstreet~~~257e03b8-9cbc-48b8-b6a5-ec526abf7b8e

    CompuGroup Medical

    +1,67 %
    +3,92 %
    +5,27 %
    +66,28 %
    -43,16 %
    -61,71 %
    -62,87 %
    +3,87 %
    +3.171,95 %
    ISIN:DE000A288904WKN:A28890


    Diskutieren Sie über die enthaltenen Werte



    EQS Group AG
    0 Follower
    Autor folgen

    Verfasst von EQS Group AG
    EQS-Adhoc CompuGroup Medical SE & Co. KGaA confirms discussions for potential significant investment of CVC EQS-Ad-hoc: CompuGroup Medical SE & Co. KGaA / Key word(s): Tender Offer CompuGroup Medical SE & Co. KGaA confirms discussions for potential significant investment of CVC 08-Dec-2024 / 23:01 CET/CEST Disclosure of an inside information acc. to …